Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Mass immunization of children has the potential to decrease infection rates and prevent the transmission of influenza. We evaluated the immunogenicity, safety, and tolerability of different formulations of cell-derived MF59-adjuvanted and nonadjuvanted A/H1N1 influenza vaccine in children and adoles...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans, Rivera, Luis, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria, Kieninger, Dorothee, Cioppa, Giovanni Della
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2015
Aiheet:
INFLUENZA/Research Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514327/
https://ncbi.nlm.nih.gov/pubmed/25621884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.987014
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia